$54.83
0.44% yesterday
Nasdaq, Apr 04, 10:02 pm CET
ISIN
US9174881089
Symbol
UTMD

Utah Medical Products, Inc. Stock price

$54.83
-4.17 7.07% 1M
-10.22 15.71% 6M
-6.64 10.80% YTD
-13.72 20.01% 1Y
-34.67 38.74% 3Y
-26.20 32.34% 5Y
-3.16 5.44% 10Y
Nasdaq, Closing price Fri, Apr 04 2025
-0.24 0.44%
ISIN
US9174881089
Symbol
UTMD
Sector

Key metrics

Market capitalization $179.94m
Enterprise Value $97.30m
P/E (TTM) P/E ratio 13.87
EV/FCF (TTM) EV/FCF 6.66
EV/Sales (TTM) EV/Sales 2.38
P/S ratio (TTM) P/S ratio 4.40
P/B ratio (TTM) P/B ratio 1.56
Dividend yield 2.20%
Last dividend (FY24) $1.21
Revenue growth (TTM) Revenue growth -18.56%
Revenue (TTM) Revenue $40.90m
EBIT (operating result TTM) EBIT $13.59m
Free Cash Flow (TTM) Free Cash Flow $14.60m
Cash position $82.98m
EPS (TTM) EPS $3.95
Short interest 2.64%
Show more

Is Utah Medical Products, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Utah Medical Products, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Utah Medical Products, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Utah Medical Products, Inc.:

Buy
100%

Financial data from Utah Medical Products, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
41 41
19% 19%
100%
- Direct Costs 19 19
27% 27%
46%
22 22
9% 9%
54%
- Selling and Administrative Expenses 4.83 4.83
655% 655%
12%
- Research and Development Expense 0.81 0.81
45% 45%
2%
16 16
29% 29%
40%
- Depreciation and Amortization 2.85 2.85
55% 55%
7%
EBIT (Operating Income) EBIT 14 14
19% 19%
33%
Net Profit 14 14
17% 17%
34%

In millions USD.

Don't miss a Thing! We will send you all news about Utah Medical Products, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Utah Medical Products, Inc. Stock News

Neutral
Accesswire
about 2 months ago
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.305) per share of common stock payable on April 3, 2025 to stockholders of record at the close of business on March 14, 2025. This is a 1.7% increase over the dividend declared in the same quarter of the p...
Neutral
Accesswire
2 months ago
SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) concluded a year of contraction. UTMD's stock price declined 27%, more than twice the EPS decline, which allowed the Company an opportunity to repurchase more than 8% of its shares in the open market.
Positive
Seeking Alpha
3 months ago
UTMD has been punished in 2024 despite high-quality business fundamentals and attractive valuation metrics. UTMD's economic characteristics are strong, with high post-tax margins and returns on capital. Projected earnings of $22mm-$31mm by FY'26E, with a valuation range of $67 to $75 per share.
More Utah Medical Products, Inc. News

Company Profile

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. It focuses on the healthcare of women and babies. Its products are used for blood pressure monitoring and blood collection, electrosurgery, gynecology, neonatal critical care, perinatology, and urology. The company was founded on April 21, 1978 and is headquartered in Midvale, UT.

Head office United States
CEO Kevin Cornwell
Employees 173
Founded 1978
Website www.utahmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today